TATVA Tatva Chintan Pharma Chem Ltd Investor Conferences Announcement 2025 - Investor Presentation Tatva Chintan Pharma Chem Ltd announced its Investor Presentation for the quarter and financial year ended March 31, 2025, showing a 3% year-over-year revenue increase to 3,935 million and an 81% rise in PAT to 96 million for Q4 FY25..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Tatva Chintan Pharma Chem Ltd